Ogawa, Wataru
Kobe University
14 papers on CoChatORCID 0000-0002-0432-4366
Most cited papers
- Verified
Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis
Yoshida, N., Emoto, T., Yamashita, T., Watanabe, H., Hayashi, T., Tabata, T., Hoshi, N., Hatano, N., Ozawa, G., Sasaki, N., et al. (2018) · Circulation
Gut microbiota and healthOral microbiology and periodontitis research
Cited by 619
- Verified
Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo
Inoue, H., Ogawa, W., Ozaki, M., Haga, S., Matsumoto, M., Furukawa, K., Hashimoto, N., Kido, Y., Mori, T., Sakaue, H., et al. (2004) · Nature Medicine
Cytokine Signaling Pathways and InteractionsMetabolism, Diabetes, and Cancer
Cited by 384
- Verified
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Kadowaki, T., Isendahl, J., Khalid, U., Lee, S. Y., Nishida, T., Ogawa, W., Tobe, K., Yamauchi, T., & Lim, S. (2022) · The Lancet Diabetes & Endocrinology
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 330
- Verified
Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease
Emoto, T., Yamashita, T., Sasaki, N., Hirota, Y., Hayashi, T., So, A., Kasahara, K., Yodoi, K., Matsumoto, T., Mizoguchi, T., et al. (2016) · Journal of Atherosclerosis and Thrombosis
Gut microbiota and healthOral microbiology and periodontitis research
Cited by 315
- Verified
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
Ogawa, W., & Sakaguchi, K. (2016) · Journal of Diabetes Investigation
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 307
- Verified
Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease
Emoto, T., Yamashita, T., Kobayashi, T., Sasaki, N., Hirota, Y., Hayashi, T., So, A., Kasahara, K., Yodoi, K., Matsumoto, T., et al. (2017) · Heart and Vessels
Gut microbiota and healthOral microbiology and periodontitis research
Cited by 174
- Verified
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
Nishizawa, H., Iguchi, G., Fukuoka, H., Takahashi, M., Suda, K., Bando, H., Matsumoto, R., Yoshida, K., Odake, Y., Ogawa, W., et al. (2016) · Scientific Reports
Liver physiology and pathologyLiver Disease Diagnosis and Treatment
Cited by 164
- Verified
Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice
Haga, S., Ogawa, W., Inoue, H., Terui, K., Ogino, T., Igarashi, R., Takeda, K., Akira, S., Enosawa, S., Furukawa, H., et al. (2005) · Journal of Hepatology
Liver physiology and pathologyOrgan Transplantation Techniques and Outcomes
Cited by 108
- Verified
The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice
Tsuchida, A., Nakagawa, T., Itakura, Y., Ichihara, J., Ogawa, W., Kasuga, M., Taiji, M., & Noguchi, H. (2001) · Diabetologia
Adipokines, Inflammation, and Metabolic DiseasesPancreatic function and diabetes
Cited by 91
- Verified
Evaluation of a Minimally Invasive System for Measuring Glucose Area under the Curve during Oral Glucose Tolerance Tests: Usefulness of Sweat Monitoring for Precise Measurement
Sakaguchi, K., Hirota, Y., Hashimoto, N., Ogawa, W., Hamaguchi, T., Matsuo, T., Miyagawa, J.-I., Namba, M., Sato, T., Okada, S., et al. (2013) · Journal of Diabetes Science and Technology
Diabetes Management and ResearchAdvancements in Transdermal Drug Delivery
Cited by 50
- Verified
Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitor
So, A., Sakaguchi, K., Okada, Y., Morita, Y., Yamada, T., Miura, H., Otowa-Suematsu, N., Nakamura, T., Komada, H., Hirota, Y., et al. (2020) · Endocrine Journal
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 45
- Verified
Effects of insulin degludec and insulin glargine U300 on glycaemic stability in individuals with type 1 diabetes: A multicentre, randomized controlled crossover study
Miura, H., Sakaguchi, K., Otowa‐Suematsu, N., Yamada, T., So, A., Komada, H., Okada, Y., Hirota, Y., Tamori, Y., & Ogawa, W. (2020) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 25
- Verified
Multiple salivary cortisol measurements are a useful tool to optimize metyrapone treatment in patients with Cushing's syndromes treatment: case presentations
Yoshida, K., Fukuoka, H., Odake, Y., Nakajima, S., Tachibana, M., Ito, J., Hosokawa, Y., Yamada, T., Miura, H., Suematsu, N., et al. (2018) · Frontiers in Endocrinology
Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders
Cited by 23
- Verified
Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism
Hirata, Y., Fukuoka, H., Iguchi, G., Iwahashi, Y., Fujita, Y., Hari, Y., Iga, M., Nakajima, S., Nishimoto, Y., Mukai, M., et al. (2015) · European Journal of Endocrinology
Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free